Armando Anido joined Auxilium as Chief Executive Officer and President and member of the Board on July 17, 2006. Mr. Anido previously served as Executive Vice President, Sales and Marketing of MedImmune, Inc. where he was also a member of that company's Executive, Product Development and Management Committees, as well as the Chair of the Commercial Strategy Team responsible for the commercial management of MedImmune's marketed brands. He currently is a member of the Board of Directors of Adolor Corporation.

Prior to MedImmune, Mr. Anido held several senior marketing positions at Glaxo Wellcome, Inc and its predecessor companies including Vice President, Central Nervous System Marketing, and Director of HIV Marketing. Prior to Glaxo Wellcome, Mr. Anido was in various sales and marketing roles at Lederle Laboratories, culminating in the role of Vice President, Anti-Infectives. Mr. Anido holds a Bachelors of Science in Pharmacy and a Masters in Business Administration from West Virginia University.